Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Receivables (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Receivables for 3 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 8.41% year-over-year to $1.0 billion, compared with a TTM value of $1.0 billion through Dec 2025, up 8.41%, and an annual FY2025 reading of $1.0 billion, up 8.41% over the prior year.
  • Receivables was $1.0 billion for Q4 2025 at BrightSpring Health Services, down from $1.0 billion in the prior quarter.
  • Across five years, Receivables topped out at $1.1 billion in Q3 2024 and bottomed at $948.2 million in Q4 2024.
  • Average Receivables over 3 years is $1.0 billion, with a median of $1.0 billion recorded in 2025.
  • Peak annual rise in Receivables hit 8.41% in 2025, while the deepest fall reached 3.94% in 2025.
  • Year by year, Receivables stood at $948.8 million in 2023, then decreased by 0.06% to $948.2 million in 2024, then grew by 8.41% to $1.0 billion in 2025.
  • Business Quant data shows Receivables for BTSG at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.